These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 3466134)

  • 21. [Value of the in vitro culture of granulomonocytic germ cells (CFU-GM) in myelodysplastic syndromes].
    Florensa L; Woessner S; Lafuente R; Almarcha J; Sans-Sabrafen J
    Sangre (Barc); 1985; 30(4-C):689-97. PubMed ID: 3867159
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic significance of magnetic resonance imaging of femoral marrow in patients with myelodysplastic syndromes.
    Takagi S; Tanaka O; Origasa H; Miura Y
    J Clin Oncol; 1999 Jan; 17(1):277-83. PubMed ID: 10458243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transmission ultrastructure in the study of acquired refractory anemias].
    Woessner S; Lafuente R; Florensa L; Vilá RM; Sans-Sabrafen J
    Sangre (Barc); 1986; 31(1):40-56. PubMed ID: 3458311
    [No Abstract]   [Full Text] [Related]  

  • 24. [Morphological changes in peripheral blood and bone marrow in patients with myelodysplastic syndromes].
    Mariańska B; Apel D; Maj S
    Acta Haematol Pol; 1991; 22(1):48-53. PubMed ID: 1823967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Choroid infiltration in myelodysplastic syndrome].
    Madjlessi F; Dann K; Althaus C; Sundmacher R; Meckenstock G
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):51-4. PubMed ID: 9743940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro culture techniques defining biological abnormalities in the myelodysplastic syndromes and myeloproliferative disorders.
    Greenberg PL
    Clin Haematol; 1986 Nov; 15(4):973-93. PubMed ID: 3552351
    [No Abstract]   [Full Text] [Related]  

  • 28. Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
    Rosati S; Anastasi J; Vardiman J
    Semin Hematol; 1996 Apr; 33(2):111-26. PubMed ID: 8722682
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute myeloblastic leukemia with trilineage myelodysplasia and CD34+ blast cells with abnormal chromatin clumping.
    Gil S; Luño E; Rodriguez JA
    Haematologica; 1998 Aug; 83(8):750-1. PubMed ID: 9793262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Transformation of a myelodysplastic to a myeloproliferative syndrome (chronic granulocytic leukemia)].
    Seewann HL
    Wien Klin Wochenschr; 1985 Mar; 97(7):320-2. PubMed ID: 3857790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukocyte alkaline phosphatase score correlation with bone marrow blast percentage in myelodysplastic syndrome.
    Lipshitz J; Limaye S; Patel D
    Acta Haematol; 2010; 124(3):179-81. PubMed ID: 20962518
    [No Abstract]   [Full Text] [Related]  

  • 32. [Myelodysplastic syndromes: preleukemic syndromes].
    Tassin F; Hermanne JP; Schaaf-Lafontaine N; Herens C; Thiry A; Paulus JM; Boniver J; Fillet G
    Rev Med Liege; 1998 Jun; 53(6):357-62. PubMed ID: 9713217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term myelodysplastic syndrome transformed into blastic leukemia].
    Dimova R; Apostolov P; Popova L
    Vutr Boles; 1988; 27(4):99-103. PubMed ID: 3213032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The distribution of marrow granulopoietic progenitors among patients with preleukemia.
    Senn JS; Curtis JE; Pinkerton PH; Till JE; McCulloch EA
    Leuk Res; 1980; 4(5):409-13. PubMed ID: 6939948
    [No Abstract]   [Full Text] [Related]  

  • 35. Proposal for a type IV blast in the FAB classification.
    Wong KF; Chan JK
    Am J Hematol; 1995 Jun; 49(2):168. PubMed ID: 7771472
    [No Abstract]   [Full Text] [Related]  

  • 36. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low blast count myeloid disorders with Auer rods: a clinicopathologic analysis of 9 cases.
    Willis MS; McKenna RW; Peterson LC; Coad JE; Kroft SH
    Am J Clin Pathol; 2005 Aug; 124(2):191-8. PubMed ID: 16040288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Philadelphia chromosome positive myelodysplastic syndrome and acute myelogenous leukemia.
    Advani AS
    Leuk Res; 2004 Jun; 28(6):545-6. PubMed ID: 15120928
    [No Abstract]   [Full Text] [Related]  

  • 39. Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature.
    Keung YK; Beaty M; Powell BL; Molnar I; Buss D; Pettenati M
    Leuk Res; 2004 Jun; 28(6):579-86. PubMed ID: 15120934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of myelodysplastic syndromes].
    Aul C; Heyll A; Gattermann N; Schneider W
    Dtsch Med Wochenschr; 1987 Feb; 112(8):309-13. PubMed ID: 3469067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.